Fairfax India will inject ₹2,000 crore into IIFL Capital at ₹350 per share, raising its stake to at least 51%.
The deal adds Fairfax India and HWIC Asia Fund Class A to the promoter group, granting nomination rights for two directors.
Fairfax currently holds ~30.5%; the infusion will bolster IIFL Capital’s balance sheet and fund growth across financial services.
Transaction is subject to shareholder and SEBI approvals, including an open offer under applicable regulations.